Milk Club: The Impact of Maternal Metabolic Disease on the Lactation Experience and Milk Bioactives

Sunday, April 30, 2023

12:30 PM – 2:00 PM ET

Location: Convention Center: Ballroom B

CE: Live CME: 1.50

Chair(s)

SK

Sarah Keim, PhD MA MS (she/her/hers)

Professor
Nationwide Children's Hospital
Columbus, Ohio, United States
Sarah Taylor, MD, MSCR (she/her/hers)

Professor
Yale University
MADISON, Connecticut, United States

Disclosure(s):

Sarah Keim, PhD MA MS: No financial relationships to disclose

Sarah N. Taylor, MD, MSCR: Astarte Medical: Speaker Honorarium including speakers bureau, symposia, and expert witness (Terminated, January 28, 2021); Ferring Pharmaceuticals: Research Support including clinical trials & the principal or named investigator (Ongoing); Pfizer: Research Support including clinical trials & the principal or named investigator (Terminated, July 27, 2022); Prolacta Bioscience: Research Support including clinical trials & the principal or named investigator (Ongoing)

Session

Description: Maternal or parent milk is the gold standard for infant nutrition, yet it is not available to all infants and much about its composition is unknown. Although most families now choose breastfeeding as their initial feeding plan, many do not achieve their lactation goal. Low milk supply is a common problem especially when maternal metabolic disease is present. Milk supply is a complex interplay of mammary gland development, hormonal signals, and milk removal behaviors all of which may be affected by metabolic health. Additionally, although studies are scant, metabolic health appears to impact milk bioactive concentrations and this bioactive variability may influence infant growth and body composition. In this 2023 Milk Club chaired by Drs. Sarah Keim and Sarah Taylor, we will delve into the existing evidence into how metabolic disease relates to both the lactation experience and milk bioactives. Dr. Laurie Nommsen-Rivers, Associate Professor of Nutritional Sciences at the University of Cincinnati College of Allied Health Sciences, will share her investigation into how low milk supply relates to hormonal signals and milk removal behaviors for women with obesity and diabetes mellitus. Dr. Brigid Gregg, Assistant Professor of Pediatrics and Nutritional Sciences at the University of Michigan, will highlight newly discovered milk bioactives and how they relate to metabolic phenotypes.

Learning Objectives:

Upon completion, participants will be able to identify the potential health benefits and challenges of breastfeeding in the context of obesity and/or diabetes.
Upon completion, participants will be able to determine the growing evidence of metabolic health signals in human milk.
Upon completion, participants will be able to identify research gaps in determining how metabolic health impacts lactation.

Presentations:

12:30 PM – 12:05 PM ET

Introduction
Speaker: Sarah Keim, PhD MA MS (she/her/hers) – Nationwide Children's Hospital
12:35 PM – 1:05 PM ET

Maternal Obesity, Metabolic Health and Milk Production
Speaker: Laurie A. Nommsen-Rivers, PhD, RD, IBCLC (she/her/hers) – University of Cincinnati
1:05 PM – 1:45 PM ET

The role of human milk bioactives in maternal-infant signaling
Speaker: Brigid Gregg, MD (she/her/hers) – University of Michigan
1:45 PM – 2:00 PM ET

Conclusion
Speaker: Sarah N. Taylor, MD, MSCR (she/her/hers) – Yale University